3rd generation glp 1 agonist third Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Targeting GLP-1, GIP & GCG
Description
Ahrn, B., Gomis, R., Standl, E., Mills, D

This reflects the fierce competition for promising new drugs

Understanding what follows helps contextualize the first 12 weeks within the larger weight loss journey

Biochem Biophys Res Commun (2019) 511(1):15460
Once you're stable on a maintenance dose, follow-up can stretch to every 3 months

Bariatric surgery typically leads to greater overall and more sustained weight loss
